MARKET WIREReuters • 2h ago
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz - ReutersIran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
Why EUDA Stock advanced +1.31% Today — RQD Quant Desk Flash
$15.50 +1.31% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $15.51
EUDA Health Holdings Limited (EUDA) carries a Roarable Rating of D- (Sell) with 39/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $46.4M
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $15.51 (+0.05%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (39/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.6% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D+
Each axis scored 0–20
12M PRICE TARGET CONE-8.6% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for EUDA)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (39/100 Composite)
🔍 WHY EUDA SCORES 39/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+11/20 pts (28% of score)
20D Institutional Volume Accumulation (±12.5% realized swing band)
▲ #2 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (28% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$18.48-16.7% Next Q
47
Q2 (-2Q)Grade D$15.40-17% Next Q
44
Q3 (-1Q)Grade D$12.78+21.3% Next Q
42
CurrentGrade D-$15.50-7.6% Hist 90D α
39
Trajectory: D (47) → D- (39)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a EUDA Turnaround Squeeze
While EUDA currently carries a cautious 39/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($15.61) and Max Pain ($16.28) forces dealer call-delta covering toward $74.76.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $EUDA• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “EUDA Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why EUDA Stock advanced +1.31% Today — RQD Quant Desk Flash
EUDA Health Holdings Limited (EUDA) advanced +1.31% to $15.50, trading at 16% of its 52-week range ($5.26 – $71.2). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 16% of its 52-week range ($5.26 – $71.2) with RSI-14 at 59.7 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $15.50 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 43.9% gross margin and $0 annual free cash flow.
Live EUDA Headlines & Catalysts
MARKET WIRECNBC • 4h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
MARKET WIRECNBC • 4h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 5h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 6h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 7h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 8h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 8h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring EUDA)
- ✓Walkthrough of EUDA's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
EUDA // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +6.68%📐 WEDGE COMPRESSION COIL
2026-10-30O $15.99H $18.00L $15.50C $15.50VOL 35.6K
RES: $19.93SUP: $12.95SMA50: $15.61SMA200: $15.45
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
EUDA Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +70.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on EUDA today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for EUDA. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for EUDA today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (EUDA)
Health Care Rank #680 of 1016
⚔️ ALPS vs EUDA Full Matrix →
1. Head-to-Head Health Care Peer Comparison (EUDA vs. ALPS, BMGL, PIII, DCGO)
Industry: Medical/Nursing Services (29 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, EUDA Health Holdings Limited (EUDA) ranks #680 by composite RQD confidence (39/100, grade D-) and #759 by equity capitalization ($46.4M). Within this direct 5-issuer industry benchmark cohort, EUDA leads on earnings valuation at N/A trailing P/E, while EUDA leads on capital efficiency and profitability with -35.0% ROIC and 43.9% gross margin. BMGL currently holds the highest overall quantitative score in the immediate peer group at 58/100 (D+) compared with EUDA at 39/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| EUDA
ACTIVE
EUDA Health Holdings Limited | D- | 39/100 | — | 43.9% | -35.0% | +1.31% | $46.4M | Benchmark Subject |
| ALPS ALPS Group Inc Ordinary Share | D+ | 57/100 | — | — | — | -0.03% | $54.1M | /alps-vs-euda → |
| BMGL Basel Medical Group Ltd | D+ | 58/100 | — | — | — | +3.26% | $36.0M | /bmgl-vs-euda → |
| PIII P3 Health Partners Inc. (Class A) | D- | 38/100 | — | — | -35.0% | +4.22% | $30.5M | /piii-vs-euda → |
| DCGO DocGo Inc. | D- | 43/100 | — | — | -35.0% | -2.43% | $27.0M | /dcgo-vs-euda → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001847846In its most recent audited fiscal period (FY2025, filed 2025-12-31), EUDA Health Holdings Limited (EUDA) reported GAAP revenue of $6.8M (+70.0% vs. FY2024 revenue of $4.0M , and +84.0% cumulative change since FY2023) , GAAP net income of -$2.8M, operating cash flow of -$2.4M, and free cash flow of -$2.5M (-17.5% YoY). On the balance sheet, EUDA closed FY2025 with $1.7M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $6.8M | -$2.8M | -$2.4M | -$2.5M | $1.7M | — |
| FY2024 (FY) | 2024-12-31 | $4.0M | -$15.4M | -$2.0M | -$2.1M | $1.7M | — |
| FY2023 (FY) | 2023-12-31 | $3.7M | -$10.0M | -$2.9M | -$2.9M | — | — |
3. EUDA Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs EUDA stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, EUDA Health Holdings Limited (NASDAQ: EUDA) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 39/100 at a spot price of $15.50 (+1.31% 1D, market cap $46.4M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, EUDA ranks #680 in composite RQD confidence.
How does EUDA compare to ALPS and BMGL in the Health Care sector?
Within the Health Care sector (Medical/Nursing Services), EUDA carries a Roarable D- (39/100 RQD), trailing P/E of N/A, gross margin of 43.9%, and ROIC of -35.0%. By comparison, ALPS (ALPS Group Inc Ordinary Share) holds a D+ grade (57/100 RQD, P/E N/A, ROIC —, cap $54.1M) and BMGL (Basel Medical Group Ltd) posts a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $36.0M). Among the 5-stock peer group, EUDA leads on earnings multiple (N/A) while EUDA leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for EUDA?
Per EUDA's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001847846), EUDA Health Holdings Limited generated $6.8M in revenue (+70.0% YoY), -$2.8M in net income, and -$2.5M in free cash flow against $1.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is EUDA trading relative to its 50-day, 200-day, and 52-week technical levels?
EUDA last traded at $15.50 (+1.31% on volume of 45,000 shares), positioning the stock -0.70% below its 50-day simple moving average ($15.61) and +0.32% above its 200-day simple moving average ($15.45). Across its 52-week range of $5.26 to $71.20, EUDA sits at the 15.5% percentile with a 14-day RSI of 59.7 (BULLISH MOMENTUM) and an implied next-earnings move of ±12.5% ($13.56 to $17.44).
EUDA Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is EUDA stock moving today?
Why EUDA Stock advanced +1.31% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.